| Your Space |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Medicine > Drug Industry Caught Covering Up Propaganda Book |
|
Your Space - Drug Industry Caught Covering Up Propaganda Book
In a recent story in the New York Daily News drug lobbyists were found to be secretly endorsing a new novel According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product aimed at scaring the American public into not ordering prescription medication from Canada. The novel foc ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in used on swaying the opinion of importing drugs from Canada in order to recoup some of the 1.7 billion dolla lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. rs lost to the Canadian market each year. In one of the most outrageous attempts of propaganda by the phar here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe maceutical companies to date, they reportedly offered $100,000 to the co-authors and publishers in an attem d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro pt to keep the details of the novel under raps when the project reportedly fell through at the end of July. ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc Julie Chrystyn began writing the novel in early April. The book details a Croatian terrorist group who u easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ses Canadian Pharmaceutical websites in order to sell fatal drugs to unsuspecting American consumers. Juli nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically e titled the book “The Spivak Conspiracy” after a good friend of hers Kenin Spivak. Spivak later joined to and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ help Julie write the book after Julie had submitted the first 50 pages to PhRMA (Pharmaceutical Research a ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi nd Manufacturers of America) for review and editorial suggestions. Spivak told New York Daily News, “They ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a said they wanted it somewhat dumbed down for women, with a lot more fluff in it, and more about the wife of dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod the head Croatian terrorist, who is a former Miss Mexico." PhRMA wanted to change these aspects in the st cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ory in order to appeal to women who are the most loyal consumers of Canadian Pharmacies. When confronted a tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen bout the propaganda novel, Ken Johnson, executive vice president of the Pharmaceutical Research and Manufac t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel turers of America acknowledged the scheme but attempted to shift the blame. Since Spivak and Chrystyn deni ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ed PhRMA’s $100,000 offer, they have since finished the latest version of the novel which is set o release y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products at the beginning of next year. If you are interested in ordering your prescription medication at 30 to 70 . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de percent less than at your local pharmacy, visit this Consumer Advocacy website for more information on orde elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Pinoy Advertising Using Flyers How To Save Money With Epson Ink Cartridge Refills
|